» Articles » PMID: 35392763

LINC01088 Promotes the Growth and Invasion of Glioma Cells Through Regulating Small Nuclear Ribonucleoprotein Polypeptide A Transcription

Overview
Journal Bioengineered
Date 2022 Apr 8
PMID 35392763
Authors
Affiliations
Soon will be listed here.
Abstract

Altered long non-coding RNAs (LncRNAs) exert pivotal parts in pathogenic processes in glioma. Here, we uncovered a differentially expressed long intergenic non-coding RNA 1088 (LINC01088) in glioma and elucidated the molecular mechanism by which LINC01088 affected the malignant phenotypes of glioma cells. Functionally, LINC01088 silencing degraded cell proliferation, invasion in glioma, while LINC01088 overexpression elicited opposite results. Mechanistically, we verified LINC01088 physically interacted with small nuclear ribonucleoprotein polypeptide A (SNRPA) and regulated the expression of SNRPA at the transcription level. Phenotypic analysis ascertained that LINC01088 substantively aggravated glioma cell progression in an SNRPA-dependent manner, and SNRPA played a pivotal part in the tumor-promoting properties of LINC01088. Our findings revealed a novel mechanism by which LINC01088 exerted pro-oncogenic functions through binding with SNRPA and transcriptionally regulating SNRPA mRNA in glioma.

Citing Articles

The pathogenesis mechanism and potential clinical value of lncRNA in gliomas.

Liu Y, Yuan H, Fan J, Wang H, Xie H, Wan J Discov Oncol. 2024; 15(1):266.

PMID: 38967893 PMC: 11226588. DOI: 10.1007/s12672-024-01144-4.


Hsa_circRNA_0084043 promoting tumorigenesis in glioma through miR-577 sponging.

Qian J, Chen C, Zhao C, Xu X, Xu Y, Zhang Y Heliyon. 2023; 9(9):e19219.

PMID: 37662721 PMC: 10469075. DOI: 10.1016/j.heliyon.2023.e19219.


LINC01088/miR-22/CDC6 Axis Regulates Prostate Cancer Progression by Activating the PI3K/AKT Pathway.

Li J, Huang X, Chen H, Gu C, Ni B, Zhou J Mediators Inflamm. 2023; 2023:9207148.

PMID: 37501932 PMC: 10371595. DOI: 10.1155/2023/9207148.


Identifying Oxidized Lipid Metabolism-Related LncRNAs as Prognostic Biomarkers of Head and Neck Squamous Cell Carcinoma.

Zhang Z, Kim B, Han W, Chen X, Yan Y, Lin L J Pers Med. 2023; 13(3).

PMID: 36983670 PMC: 10054813. DOI: 10.3390/jpm13030488.


Long noncoding RNA LINC01088 inhibits esophageal squamous cell carcinoma progression by targeting the NPM1-HDM2-p53 axis.

Liang F, Luo Q, Han H, Zhang J, Yang Y, Chen J Acta Biochim Biophys Sin (Shanghai). 2023; 55(3):367-381.

PMID: 36942988 PMC: 10160232. DOI: 10.3724/abbs.2023021.

References
1.
Schmitz S, Grote P, Herrmann B . Mechanisms of long noncoding RNA function in development and disease. Cell Mol Life Sci. 2016; 73(13):2491-509. PMC: 4894931. DOI: 10.1007/s00018-016-2174-5. View

2.
Diao P, Ge H, Song Y, Wu Y, Li J, Li Z . Overexpression of ZEB2-AS1 promotes epithelial-to-mesenchymal transition and metastasis by stabilizing ZEB2 mRNA in head neck squamous cell carcinoma. J Cell Mol Med. 2019; 23(6):4269-4280. PMC: 6533490. DOI: 10.1111/jcmm.14318. View

3.
Yu X, Lin Q, Liu F, Yang F, Mao J, Chen X . LncRNA TMPO-AS1 facilitates the proliferation and metastasis of NSCLC cells by up-regulating ERBB2 via sponging miR-204-3p. Int J Immunopathol Pharmacol. 2020; 34:2058738420958947. PMC: 7520928. DOI: 10.1177/2058738420958947. View

4.
Jia R, Chai P, Wang S, Sun B, Xu Y, Yang Y . mA modification suppresses ocular melanoma through modulating HINT2 mRNA translation. Mol Cancer. 2019; 18(1):161. PMC: 6854757. DOI: 10.1186/s12943-019-1088-x. View

5.
Saw P, Xu X, Chen J, Song E . Non-coding RNAs: the new central dogma of cancer biology. Sci China Life Sci. 2020; 64(1):22-50. DOI: 10.1007/s11427-020-1700-9. View